ATS Medical to sell Regeneration Tech cardiovascular tissue processing:
This article was originally published in Clinica
Minneapolis, Minnesota-based cardiac surgery products maker ATS Medical is to promote, market and solicit orders for Regeneration Technologies' processed cardiovascular allograft tissue under an exclusive deal effective from July 21. Alachua, Florida-based Regeneration Technologies' cardiovascular subsidiary, formerly known as Alabama Tissue Center, processes heart valves, veins, arteries, patches and other cardiovascular tissue for reconstructing congenital abnormalities in children and repairing adults' heart valves. The US market for cardiovascular allograft tissue is worth around $40m.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.